Mainstream

Bristol Myers To Report Q4 Iprd/licensing Expense Of $18m

Bristol Myers to report Q4 IPRD/licensing expense of $18M

Bristol Myers to report Q4 IPRD/licensing expense of $18M

Post ContentbmyRead More

You might also be interested in reading Russia Legalizes Crypto Mining and Brings an Experimental Regime.

January 6, 2025
In Mainstream